Literature DB >> 18043272

Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease.

Arthur F Gelb1, Noe Zamel, Anita Krishnan.   

Abstract

PURPOSE OF REVIEW: This review examines the physiologic mechanisms responsible for persistent maximum expiratory airflow limitation in nonsmoking patients with acute and chronic moderate to severe persistent asthma in comparison to chronic obstructive pulmonary disease. RECENT
FINDINGS: The phenomenon of acute but reversible loss of lung elastic recoil during acute asthma is reviewed, although no plausible pathophysiologic explanation has been offered. Nonsmoking adults with stable asthma and persistent maximum expiratory airflow limitation, despite optimal polytherapy, were shown to have unsuspected and unexplained marked loss of lung elastic recoil in the absence of lung computed tomography scored emphysema. This condition resulted in up to 50% reduction in maximum expiratory airflow. Furthermore, these patients remain at high risk for adverse clinical events, including near-fatal asthma. In chronic obstructive pulmonary disease, reduction in maximum expiratory airflow is related to variable extent of loss of lung elastic recoil secondary to emphysema and concurrent intrinsic airway obstruction or obliteration of small airways. There is also an unexplained loss of lung elastic recoil in primary intrinsic small airways disease in the absence of emphysema.
SUMMARY: Nonsmoking patients with moderate-severe persistent asthma and patients with smoking-related chronic obstructive pulmonary disease share similar physiologic mechanisms of expiratory airflow limitation, but probably caused by different anatomic abnormalities.

Entities:  

Mesh:

Year:  2008        PMID: 18043272     DOI: 10.1097/MCP.0b013e3282f197df

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  5 in total

Review 1.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.

Authors:  Urs Frey; Béla Suki
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Pulmonary kinematics from tagged hyperpolarized helium-3 MRI.

Authors:  Nicholas J Tustison; Suyash P Awate; Jing Cai; Talissa A Altes; G Wilson Miller; Eduard E de Lange; John P Mugler; James C Gee
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

3.  Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-γ.

Authors:  Byung-Jae Lee; Hyung-Geun Moon; Tae-Seop Shin; Seong Gyu Jeon; Eun-Young Lee; Yong Song Gho; Chun Geun Lee; Zhou Zhu; Jack A Elias; Yoon-Keun Kim
Journal:  Exp Mol Med       Date:  2011-04-30       Impact factor: 8.718

4.  The search for common pathways underlying asthma and COPD.

Authors:  Yoshiko Kaneko; Yohei Yatagai; Hideyasu Yamada; Hiroki Iijima; Hironori Masuko; Tohru Sakamoto; Nobuyuki Hizawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25

5.  Evaluation of multidrug resistance-1 gene C>T polymorphism frequency in patients with asthma.

Authors:  Ümran Toru; Ceylan Ayada; Osman Genç; Zehra Yaşar; Server Şahin; Emre Taşkın; İsmet Bulut; Murat Acat
Journal:  Clinics (Sao Paulo)       Date:  2015-10       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.